News Headlines Article

Verma exploring outcome-based ideas to tackle high drug costs
Modern Healthcare

CMS Administrator Seema Verma said Wednesday there need to be “serious discussions” on how to pay for new and extremely pricey drug innovations but slammed the idea of giving Medicare negotiating power.

Verma told reporters that Medicare and Medicaid’s payment systems were not expected to deal with high costs for new and curative innovations.

“Last year we had a new drug for blindness that is about $850,000 and now we are hearing about price tags that could be reaching $5 million for a treatment,” Verma said.